Ligand validation:3ASO

CHD: CHOLIC ACID

CHD is a Ligand Of Interest in 3ASO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3ASO_CHD_G_229	89%	37%	0.099	0.98	0.89	1.55	-	10	0	0	100%	1
3ASO_CHD_B_1085	82%	34%	0.11	0.966	1.13	1.47	4	9	2	0	100%	1
3ASO_CHD_P_1525	78%	39%	0.11	0.952	0.94	1.41	1	7	0	0	100%	1
3ASO_CHD_C_525	73%	53%	0.131	0.958	0.81	0.99	-	2	0	0	100%	1
3ASO_CHD_C_271	10%	32%	0.262	0.761	0.62	2.05	-	18	3	0	100%	1
3ASO_CHD_P_1271	9%	31%	0.242	0.737	0.62	2.07	-	16	1	0	100%	1
3ASO_CHD_J_60	1%	16%	0.411	0.523	0.81	2.86	-	22	3	0	100%	1
3ASO_CHD_W_1059	0%	13%	0.424	0.484	0.84	3.09	-	21	4	0	100%	1
7TIE_CHD_G_107	98%	64%	0.052	0.977	0.64	0.75	-	-	0	0	100%	1
3AG2_CHD_B_304	97%	32%	0.063	0.981	1.03	1.63	3	12	0	0	100%	1
6NMP_CHD_C_303	96%	58%	0.075	0.982	0.56	1.02	-	2	1	0	100%	1
7VUW_CHD_B_305	96%	32%	0.064	0.97	1.01	1.67	-	13	0	0	100%	1
7YPY_CHD_B_303	95%	35%	0.057	0.962	1.09	1.48	2	10	0	0	100%	1
5B1B_CHD_G_103	95%	40%	0.058	0.962	0.87	1.45	1	6	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.